申请人:Agouron Pharmaceuticals, Inc.
公开号:US05985900A1
公开(公告)日:1999-11-16
Compounds of the formula I: ##STR1## wherein Y is O or S, Ar is an aryl group or a heteroaryl group, R is H, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or --C(O)R.sub.1, wherein R.sub.1 is hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, or NR.sub.2 R.sub.3, wherein R.sub.2 and R.sub.3 independently are hydrogen, an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group, and X is --NH--OH or --OH. Pharmaceutically acceptable prodrugs, salts and solvates of these compounds. Methods of inhibiting the activity of metalloproteinases by administering a compound of the formula I or a prodrug, salt of solvate thereof. Pharmaceutical compositions comprising an effective amount of these compounds, prodrugs, salts, and solvates.
公式I的化合物:##STR1## 其中Y是O或S,Ar是芳基团或杂芳基团,R是H,烷基团,环烷基团,杂环烷基团,芳基团,杂芳基团或--C(O)R.sub.1,其中R.sub.1是氢,烷基团,环烷基团,杂环烷基团,芳基团,杂芳基团或NR.sub.2 R.sub.3,其中R.sub.2和R.sub.3独立的是氢,烷基团,环烷基团,杂环烷基团,芳基团或杂芳基团,X是--NH--OH或--OH。这些化合物的药物可接受的的前药,盐和溶剂化物。通过管理公式I的化合物或前药,盐或溶剂化物抑制金属蛋白酶活性的方法。包含有效量的这些化合物,前药,盐和溶剂化物的药物组合物。